{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T01:10:29Z","timestamp":1789089029120,"version":"build-2803163510"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":77,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-026-28286-0","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T07:26:22Z","timestamp":1782458782000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HBV breakthrough infection in individuals born to mothers with HBV infection: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Yuchen","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifang","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"28286_CR1","unstructured":"World Health Organization. Global hepatitis report 2024: action for access in low- and middle-income countries. Geneva: World Health Organization; 2024. https:\/\/www.who.int\/publications\/i\/item\/9789240091672"},{"issue":"8","key":"28286_CR2","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41575-023-00760-9","volume":"20","author":"YC Hsu","year":"2023","unstructured":"Hsu YC, Huang DQ, Nguyen MH. Global burden of hepatitis B virus: current status, missed opportunities and a call for action. Nat reviews Gastroenterol Hepatol. 2023;20(8):524\u201337.","journal-title":"Nat reviews Gastroenterol Hepatol"},{"issue":"1","key":"28286_CR3","doi-asserted-by":"publisher","first-page":"2473222","DOI":"10.1080\/21645515.2025.2473222","volume":"21","author":"E Broeckhoven","year":"2025","unstructured":"Broeckhoven E, Dallmeier K. Mission 2030: Toward universal hepatitis B immunization. Hum vaccines immunotherapeutics. 2025;21(1):2473222.","journal-title":"Hum vaccines immunotherapeutics"},{"issue":"9","key":"28286_CR4","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/S2468-1253(22)00124-8","volume":"7","author":"regional Global","year":"2022","unstructured":"Global regional, national burden of hepatitis B. 1990\u20132019: a systematic analysis for the global burden of disease study 2019. lancet Gastroenterol Hepatol. 2022;7(9):796\u2013829.","journal-title":"lancet Gastroenterol Hepatol"},{"issue":"1","key":"28286_CR5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.21037\/hbsn-2024-754","volume":"14","author":"R Yan","year":"2025","unstructured":"Yan R, Sun M, Yang H, Du S, Sun L, Mao Y. 2024 latest report on hepatitis B virus epidemiology in China: current status, changing trajectory, and challenges. Hepatobiliary Surg Nutr. 2025;14(1):66\u201377.","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"29","key":"28286_CR6","doi-asserted-by":"publisher","first-page":"648","DOI":"10.15585\/mmwr.mm7329a3","volume":"73","author":"MM Alleman","year":"2024","unstructured":"Alleman MM, Sereno LS, Whittembury A, Li X, Contreras M, Pacis-Tirso C, et al. Progress toward elimination of mother-to-child transmission of hepatitis B virus - region of the Americas, 2012\u20132022. MMWR Morb Mortal Wkly Rep. 2024;73(29):648\u201355.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"28286_CR7","doi-asserted-by":"publisher","first-page":"100798","DOI":"10.1016\/j.epidem.2024.100798","volume":"49","author":"MJ de Villiers","year":"2024","unstructured":"de Villiers MJ, de Villiers E, Nayagam S, Hallett TB. Direct and indirect effects of hepatitis B vaccination in four low- and middle-income countries. Epidemics. 2024;49:100798.","journal-title":"Epidemics"},{"issue":"3","key":"28286_CR8","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.vaccine.2009.10.068","volume":"28","author":"J Poorolajal","year":"2010","unstructured":"Poorolajal J, Mahmoodi M, Majdzadeh R, Nasseri-Moghaddam S, Haghdoost A, Fotouhi A. Long-term protection provided by hepatitis B vaccine and need for booster dose: a meta-analysis. Vaccine. 2010;28(3):623\u201331.","journal-title":"Vaccine"},{"issue":"9","key":"28286_CR9","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1097\/01.inf.0000176617.63457.9f","volume":"24","author":"CM Dentinger","year":"2005","unstructured":"Dentinger CM, McMahon BJ, Butler JC, Dunaway CE, Zanis CL, Bulkow LR, et al. Persistence of antibody to hepatitis B and protection from disease among Alaska natives immunized at birth. Pediatr Infect Dis J. 2005;24(9):786\u201392.","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"28286_CR10","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1186\/s12879-022-07854-w","volume":"22","author":"Y Song","year":"2022","unstructured":"Song Y, Zhang X, Liu M, Zhai X, Liu J, Li Y, et al. A booster hepatitis B vaccine for children with maternal HBsAg positivity before 2 years of age could effectively prevent vaccine breakthrough infections. BMC Infect Dis. 2022;22(1):863.","journal-title":"BMC Infect Dis"},{"issue":"9","key":"28286_CR11","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jclinepi.2011.11.014","volume":"65","author":"D Hoy","year":"2012","unstructured":"Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C, et al. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 2012;65(9):934\u20139.","journal-title":"J Clin Epidemiol"},{"key":"28286_CR12","doi-asserted-by":"publisher","first-page":"127128","DOI":"10.1016\/j.vaccine.2025.127128","volume":"54","author":"F Wang","year":"2025","unstructured":"Wang F, Zheng J, Qiu F, Yang Y, Li Q, Che X, et al. Long-term effectiveness of vaccination for prevention of hepatitis B virus mother-to-child transmission in Yunnan, China. Vaccine. 2025;54:127128.","journal-title":"Vaccine"},{"issue":"6","key":"28286_CR13","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1007\/s15010-024-02290-1","volume":"52","author":"A Eilard","year":"2024","unstructured":"Eilard A, Andersson ME, Wejstal R, Norkrans G, Lindh M. Occult hepatitis B infection in children born to HBeAg-positive women confers a low long-term risk for HBsAg-positive infection. Infection. 2024;52(6):2351\u20137.","journal-title":"Infection"},{"issue":"05","key":"28286_CR14","first-page":"833","volume":"28","author":"CY Xu","year":"2021","unstructured":"Xu CY, Chen T, huang M, Wang HY, Hu Q, Zhou YL. Y H. Evaluation of long-term protective efficacy of neonatal immunoprophylaxis in children whose mothers have hepatitis B virus [in Chinese]. Chin J Clin Med. 2021;28(05):833\u20137.","journal-title":"Chin J Clin Med"},{"issue":"17","key":"28286_CR15","first-page":"2654","volume":"43","author":"H An","year":"2021","unstructured":"An H, Lv B, Wang J, Chang TF, yANG YF. Study on the long-term protective effect of immune response of newborns of HBsAg positive mothers after hepatitis B vaccination [in Chinese]. Hebei Med J. 2021;43(17):2654\u20136.","journal-title":"Hebei Med J"},{"issue":"4","key":"28286_CR16","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.vaccine.2019.10.100","volume":"38","author":"M Insulander","year":"2020","unstructured":"Insulander M, Lindh G, Stenkvist J, Samuelson A, Fischler B. Long-term follow-up of a vaccination program for infants born to HBsAg-positive mothers in Stockholm County, Sweden. Vaccine. 2020;38(4):790\u20133.","journal-title":"Vaccine"},{"issue":"10","key":"28286_CR17","first-page":"888","volume":"41","author":"H Zou","year":"2019","unstructured":"Zou H, Zhao B, Chen MY, Zheng Y, Zhang SJ, Duan H. Immune protection effect and persistence of passive-active immunization in infants delivered by HBsAg-positive mothers [in Chinese]. Beijing Med J. 2019;41(10):888\u201391.","journal-title":"Beijing Med J"},{"issue":"22","key":"28286_CR18","first-page":"1724","volume":"33","author":"Y Rui","year":"2018","unstructured":"Rui Y, Dai Y, Zheng Y, Ning M, Xu Z, Wang Z, et al. Long-term protection of infants against hepatitis B by neonatal immunoprophylaxis born from mothers infected with hepatitis B virus [in Chinese]. Chin J Appl Clin Pediatr. 2018;33(22):1724\u20136.","journal-title":"Chin J Appl Clin Pediatr"},{"issue":"05","key":"28286_CR19","first-page":"438","volume":"29","author":"X Dong","year":"2017","unstructured":"Dong X, Tang Z, Wang X, Chen Y, Chen S, Wang X, et al. An observation on the long-term efficacy of recombinant hepatitis B vaccines among the newborns [in Chinese]. Prev Med. 2017;29(05):438\u201342.","journal-title":"Prev Med"},{"issue":"7","key":"28286_CR20","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.vaccine.2016.12.062","volume":"35","author":"Y Wang","year":"2017","unstructured":"Wang Y, Chen T, Lu LL, Wang M, Wang D, Yao H, et al. Adolescent booster with hepatitis B virus vaccines decreases HBV infection in high-risk adults. Vaccine. 2017;35(7):1064\u201370.","journal-title":"Vaccine"},{"issue":"8","key":"28286_CR21","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1007\/s00705-017-3365-6","volume":"162","author":"LLA Rodr\u00edguez Lay","year":"2017","unstructured":"Rodr\u00edguez Lay LLA, Bello Corredor M, Montalvo Villalba MC, Chib\u00e1s Ojeda AG, Sariego Fr\u00f3meta S, Diaz Gonz\u00e1lez M, et al. Hepatitis B virus infection assessed 3 to 18 years after vaccination in Cuban children and adolescents born to HBsAg-positive mothers. Arch Virol. 2017;162(8):2393\u20136.","journal-title":"Arch Virol"},{"key":"28286_CR22","first-page":"616","volume":"22","author":"Y Feng","year":"2016","unstructured":"Feng Y, Yan B, Lv Y, Liu JJ, Wu JY, Liang WL. Immune persistence from hepatitis B vaccination among infants with normal and high espon ses to primary immunization: a 5-year follow-up study [in Chinese]. Chin J Vaccines Immun. 2016;22:616\u201320.","journal-title":"Chin J Vaccines Immun"},{"key":"28286_CR23","doi-asserted-by":"crossref","unstructured":"Takano T, Tajiri H, Etani Y, Miyoshi YJK. Latent hepatitis B virus infection among children who were successfully protected from perinatal HBV infection via HBV carrier mothers. Kanzo. 2016;57(10):554\u20136.","DOI":"10.2957\/kanzo.57.554"},{"key":"28286_CR24","unstructured":"Ni HX. Regulation of hepatitis B virus mutation and effect of immunoprophylaxis in mother-to-child transmission [dissertation]. Shanghai: Second Military Medical University; 2013."},{"issue":"6","key":"28286_CR25","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.jhep.2013.08.021","volume":"59","author":"AW Lin","year":"2013","unstructured":"Lin AW, Wong KH. Long-term protection of neonatal hepatitis B vaccination in a 30-year cohort in Hong Kong. J Hepatol. 2013;59(6):1363\u20134.","journal-title":"J Hepatol"},{"issue":"3","key":"28286_CR26","first-page":"238","volume":"39","author":"Q Yao","year":"2012","unstructured":"Yao Q, Dong Q, Wang XL, Wang XC, Xu FD, Wang HT. The 13-year-lasting efficacy of yeast-derived hepatitis B vaccines among the newborns[in Chinese]. Fudan Univ J Med Sci. 2012;39(3):238\u20134252.","journal-title":"Fudan Univ J Med Sci"},{"issue":"9","key":"28286_CR27","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.vaccine.2011.12.106","volume":"30","author":"SS Chaves","year":"2012","unstructured":"Chaves SS, Fischer G, Groeger J, Patel PR, Thompson ND, Teshale EH, et al. Persistence of long-term immunity to hepatitis B among adolescents immunized at birth. Vaccine. 2012;30(9):1644\u20139.","journal-title":"Vaccine"},{"issue":"4","key":"28286_CR28","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1053\/j.gastro.2011.12.035","volume":"142","author":"HL Chen","year":"2012","unstructured":"Chen HL, Lin LH, Hu FC, Lee JT, Lin WT, Yang YJ, et al. Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV. Gastroenterology. 2012;142(4):773\u2013e812.","journal-title":"Gastroenterology"},{"issue":"5","key":"28286_CR29","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s15010-010-0039-7","volume":"38","author":"L Roznovsky","year":"2010","unstructured":"Roznovsky L, Orsagova I, Kloudova A, Tvrdik J, Kabieszova L, Lochman I, et al. Long-term protection against hepatitis B after newborn vaccination: 20-year follow-up. Infection. 2010;38(5):395\u2013400.","journal-title":"Infection"},{"issue":"6","key":"28286_CR30","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1002\/hep.20490","volume":"40","author":"CY Lu","year":"2004","unstructured":"Lu CY, Chiang BL, Chi WK, Chang MH, Ni YH, Hsu HM, et al. Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination. Hepatology (Baltimore MD). 2004;40(6):1415\u201320.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"7","key":"28286_CR31","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1086\/423818","volume":"190","author":"EH Boxall","year":"2004","unstructured":"Boxall EH, El-Shuhkri JAS, Kelly N. Long-term persistence of immunity to hepatitis B after vaccination during infancy in a country where endemicity is low. J Infect Dis. 2004;190(7):1264\u20139.","journal-title":"J Infect Dis"},{"key":"28286_CR32","unstructured":"Ma JC, Liu HB, Zhang YL, Meng ZD, Han CQ, Xing ZC, et al. An evaluation on the effectiveness of plasma-derived hepatitis B vaccine immunization in newborns after 14 years [in Chinese]. Chinese Journal of Vaccines and Immunization. 2003;9(3):7\u20139."},{"issue":"6","key":"28286_CR33","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1086\/314768","volume":"179","author":"JS Wu","year":"1999","unstructured":"Wu JS, Hwang LY, Goodman KJ, Beasley RP. Hepatitis B vaccination in high-risk infants: 10-year follow-up. J Infect Dis. 1999;179(6):1319\u201325.","journal-title":"J Infect Dis"},{"issue":"3","key":"28286_CR34","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1002\/hep.510290349","volume":"29","author":"LM Huang","year":"1999","unstructured":"Huang LM, Chiang BL, Lee CY, Lee PI, Chi WK, Chang MH. Long-term response to hepatitis B vaccination and response to booster in children born to mothers with hepatitis B e antigen. Hepatology (Baltimore MD). 1999;29(3):954\u20139.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"12\u201313","key":"28286_CR35","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/S0264-410X(97)00028-5","volume":"15","author":"M Resti","year":"1997","unstructured":"Resti M, Azzari C, Mannelli F, Rossi ME, Lionetti P, Vierucci A. Ten-year follow-up study of neonatal hepatitis B immunization: are booster injections indicated? Vaccine. 1997;15(12\u201313):1338\u201340.","journal-title":"Vaccine"},{"issue":"1","key":"28286_CR36","doi-asserted-by":"publisher","first-page":"F47","DOI":"10.1136\/fn.77.1.F47","volume":"77","author":"Y Poovorawan","year":"1997","unstructured":"Poovorawan Y, Sanpavat S, Chumdermpadetsuk S, Safary A. Long-term hepatitis B vaccine in infants born to hepatitis B e antigen positive mothers. Archives disease Child Fetal neonatal Ed. 1997;77(1):F47\u201351.","journal-title":"Archives disease Child Fetal neonatal Ed"},{"key":"28286_CR37","unstructured":".Cheng QF, Yang DZ, Wu YR. The protective effects of hepatitis B vaccine at different doses[in Chinese]. Chin Med Fact Mine. 1996(02):131\u20133."},{"key":"28286_CR38","unstructured":"Lin DD, Lu CK, Jiang ZY, He GH, Zheng XQ, He CF. Follow-up observation on the efficacy of hepatitis B vaccine in newborns of HBsAg -positive mothers[in Chinese]. Jiangsu J Prev Med. 1996(02):9."},{"issue":"3","key":"28286_CR39","first-page":"270","volume":"23","author":"T Fujisawa","year":"1996","unstructured":"Fujisawa T, Onoue M, Inui A, Kosugi T. Serial changes in titers of antibody to hepatitis B surface antigen after immunization of infants born to mothers with hepatitis B e antigen. J Pediatr Gastroenterol Nutr. 1996;23(3):270\u20134.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5 Pt 1","key":"28286_CR40","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/S0022-3476(95)70398-5","volume":"126","author":"PI Lee","year":"1995","unstructured":"Lee PI, Lee CY, Huang LM, Chang MH. Long-term efficacy of recombinant hepatitis B vaccine and risk of natural infection in infants born to mothers with hepatitis B e antigen. J Pediatr. 1995;126(5 Pt 1):716\u201321.","journal-title":"J Pediatr"},{"issue":"1","key":"28286_CR41","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1093\/infdis\/171.1.54","volume":"171","author":"ZY Xu","year":"1995","unstructured":"Xu ZY, Duan SC, Margolis HS, Purcell RH, Ou-Yang PY, Coleman PJ, et al. Long-term efficacy of active postexposure immunization of infants for prevention of hepatitis B virus infection. United States-People\u2019s Republic of China Study Group on Hepatitis B. J Infect Dis. 1995;171(1):54\u201360.","journal-title":"J Infect Dis"},{"issue":"17","key":"28286_CR42","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/0264-410X(95)00108-D","volume":"13","author":"PI Lee","year":"1995","unstructured":"Lee PI, Lee CY, Huang LM, Chen JM, Chang MH. A follow-up study of combined vaccination with plasma-derived and recombinant hepatitis B vaccines in infants. Vaccine. 1995;13(17):1685\u20139.","journal-title":"Vaccine"},{"key":"28286_CR43","unstructured":"Zheng JM, Meng XY, Ren K, Li Y. Long-term efficacy of plasma-derived hepatitis B vaccine at different doses in newborns: a follow-up study [in Chinese]. Progress in Microbiology and Immunology. 1994;22(3):39\u201342"},{"issue":"8","key":"28286_CR44","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1093\/oxfordjournals.aje.a117321","volume":"140","author":"SA Marion","year":"1994","unstructured":"Marion SA, Tomm Pastore M, Pi DW, Mathias RG. Long-term follow-up of hepatitis B vaccine in infants of carrier mothers. Am J Epidemiol. 1994;140(8):734\u201346.","journal-title":"Am J Epidemiol"},{"issue":"12","key":"28286_CR45","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/0264-410X(94)90173-2","volume":"12","author":"PM Grosheide","year":"1994","unstructured":"Grosheide PM, del Canho R, Voogd M, Heijtink RA, Schalm SW. Anti-HBs levels in infants of hepatitis B carrier mothers after delayed active immunization with recombinant vaccine concomitant with DTP-polio vaccine: is there need for a second dose of HBIg? Dutch Study Group on Prevention of Neonatal Hepatitis B. Vaccine. 1994;12(12):1059\u201363.","journal-title":"Vaccine"},{"issue":"10","key":"28286_CR46","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/0264-410X(93)90129-L","volume":"11","author":"ML Gonzalez","year":"1993","unstructured":"Gonzalez ML, Gonzalez JB, Salva F, Lardinois R. A 7-year follow-up of newborns vaccinated against hepatitis B. Vaccine. 1993;11(10):1033\u20136.","journal-title":"Vaccine"},{"issue":"3","key":"28286_CR47","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1093\/clinids\/17.3.475","volume":"17","author":"L Ding","year":"1993","unstructured":"Ding L, Zhang M, Wang Y, Zhou S, Kong W, Smego RA. Jr. A 9-year follow-up study of the immunogenicity and long-term efficacy of plasma-derived hepatitis B vaccine in high-risk Chinese neonates. Clin Infect diseases: official publication Infect Dis Soc Am. 1993;17(3):475\u20139.","journal-title":"Clin Infect diseases: official publication Infect Dis Soc Am"},{"issue":"2","key":"28286_CR48","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/j.1447-0756.1989.tb00162.x","volume":"15","author":"U Theppisai","year":"1989","unstructured":"Theppisai U, Thanuntaseth C, Chiewsilp P, Siripoonya P. Long-term immunoprophylaxis of hepatitis B surface antigen carrier in infants born to hepatitis B surface antigen positive mothers using plasma derived vaccine. Asia-Oceania J Obstet Gynecol. 1989;15(2):111\u20135.","journal-title":"Asia-Oceania J Obstet Gynecol"},{"issue":"6","key":"28286_CR49","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1002\/hep.1840080629","volume":"8","author":"KJ Lo","year":"1988","unstructured":"Lo KJ, Lee SD, Tsai YT, Wu TC, Chan CY, Chen GH, et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in infants born to HBeAg-positive HBsAg-carrier mothers. Hepatology (Baltimore MD). 1988;8(6):1647\u201350.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"8523","key":"28286_CR50","first-page":"49","volume":"1","author":"L Viladomiu","year":"1987","unstructured":"Viladomiu L, Genesca J, Esteban JI, Esteban R, Hernandez JM, Guardia J. When should at-risk infants be boosted with hepatitis B vaccine? Lancet (London. England). 1987;1(8523):49.","journal-title":"England)"},{"issue":"11","key":"28286_CR51","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/nrgastro.2016.138","volume":"13","author":"JP Allain","year":"2016","unstructured":"Allain JP, Opare-Sem O. Screening and diagnosis of HBV in low-income and middle-income countries. Nat reviews Gastroenterol Hepatol. 2016;13(11):643\u201353.","journal-title":"Nat reviews Gastroenterol Hepatol"},{"issue":"3","key":"28286_CR52","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s12072-025-10816-4","volume":"19","author":"YC Pan","year":"2025","unstructured":"Pan YC, Jia ZF , Zhang YY , Wu YH , Jiang J. Estimates of the global prevalence of occult hepatitis B virus infection in population under 18 years old: a systematic review and meta-analysis. Hep Intl. 2025;19(3):493\u2013506.","journal-title":"Hep Intl"},{"issue":"1","key":"28286_CR53","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S1473-3099(20)30593-4","volume":"21","author":"P Boucheron","year":"2021","unstructured":"Boucheron P, Lu Y, Yoshida K, Zhao T, Funk AL, Lunel-Fabiani F, et al. Accuracy of HBeAg to identify pregnant women at risk of transmitting hepatitis B virus to their neonates: a systematic review and meta-analysis. Lancet Infect Dis. 2021;21(1):85\u201396.","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"28286_CR54","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1111\/j.1365-2893.2011.01492.x","volume":"19","author":"H Zou","year":"2012","unstructured":"Zou H, Chen Y, Duan Z, Zhang H, Pan C. Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers. J Viral Hepatitis. 2012;19(2):e18\u201325.","journal-title":"J Viral Hepatitis"},{"key":"28286_CR55","doi-asserted-by":"crossref","unstructured":"Phattraprayoon N, Kakheaw J, Soonklang K, Cheirsilpa K, Ungtrakul T, Auewarakul C, et al. Duration of hepatitis B vaccine-induced protection among medical students and healthcare workers following primary vaccination in infancy and rate of immunity decline. Vaccines. 2022;10(2):267.","DOI":"10.3390\/vaccines10020267"},{"issue":"5","key":"28286_CR56","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1080\/21645515.2018.1426419","volume":"14","author":"Z Wu","year":"2018","unstructured":"Wu Z, Yao J, Bao H, Chen Y, Lu S, Li J, et al. The effects of booster vaccination of hepatitis B vaccine on children 5\u201315 years after primary immunization: A 5-year follow-up study. Hum vaccines immunotherapeutics. 2018;14(5):1251\u20136.","journal-title":"Hum vaccines immunotherapeutics"},{"key":"28286_CR57","unstructured":"World Health Organization. Hepatitis B vaccines: WHO position paper \u2013 July 2017. Weekly Epidemiological Record. 2017;92(27):369\u2013392. https:\/\/www.who.int\/publications\/i\/item\/WER9227"},{"issue":"1","key":"28286_CR58","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12916-021-02025-1","volume":"19","author":"X Zhang","year":"2021","unstructured":"Zhang X, Zou H, Chen Y, Zhang H, Tian R, Meng J, et al. The effects of increased dose of hepatitis B vaccine on mother-to-child transmission and immune response for infants born to mothers with chronic hepatitis B infection: a prospective, multicenter, large-sample cohort study. BMC Med. 2021;19(1):148.","journal-title":"BMC Med"},{"issue":"9","key":"28286_CR59","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1097\/00006454-199609000-00004","volume":"15","author":"J Goldfarb","year":"1996","unstructured":"Goldfarb J, Medendorp SV, Garcia H, Nagamori K, Rathfon H, Krause D. Comparison study of the immunogenicity and safety of 5- and 10-microgram dosages of a recombinant hepatitis B vaccine in healthy infants. Pediatr Infect Dis J. 1996;15(9):764\u20137.","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"28286_CR60","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1080\/22221751.2020.1808533","volume":"9","author":"AY Li","year":"2020","unstructured":"Li AY, Liu Z, Song Y, Xiao Y, Jiang J, Li L, et al. Reduction of the occurrence of occult HBV infection in infants by increasing the dose of hepatitis B vaccine: a large prospective cohort study. Emerg microbes infections. 2020;9(1):1881\u201391.","journal-title":"Emerg microbes infections"},{"key":"28286_CR61","doi-asserted-by":"crossref","unstructured":"Mahmood F, Xu R, Awan MUN, Song Y, Han Q, Xia X, et al. HBV vaccines: advances and development. Vaccines (Basel). 2023;11(12):1862.","DOI":"10.3390\/vaccines11121862"},{"issue":"2","key":"28286_CR62","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/jmv.1890270217","volume":"27","author":"L Butterly","year":"1989","unstructured":"Butterly L, Watkins E, Dienstag JL. Recombinant-yeast-derived hepatitis B vaccine in healthy adults: safety and two-year immunogenicity of early investigative lots of vaccine. J Med Virol. 1989;27(2):155\u20139.","journal-title":"J Med Virol"},{"issue":"1","key":"28286_CR63","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0163-4453(88)92332-8","volume":"17","author":"J Hayashi","year":"1988","unstructured":"Hayashi J, Kashiwagi S, Kajiyama W, Ikematsu H, Noguchi A, Nomura H, et al. Comparison of results of recombinant and plasma-derived hepatitis B vaccines in Japanese nursery-school children. J Infect. 1988;17(1):49\u201355.","journal-title":"J Infect"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-026-28286-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-28286-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-28286-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T01:02:31Z","timestamp":1789088551000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-026-28286-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["28286"],"URL":"https:\/\/doi.org\/10.1186\/s12889-026-28286-0","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"15 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"2580"}}